99%min Diclofenac Potassium CAS 15307-81-0 CAS NO.15307-81-0

Min.Order Quantity:: 10 Gram

Purity:: 99%min

Port:: ShangHai

Payment Terms:: T/T,MoneyGram

Add to Inquiry Cart

Product Details

Keywords

99%min Diclofenac Potassium
Diclofenac Potassium Manufacturer
For Anti-inflammatory Analgesics

Quick Details

ProName: 99%min Diclofenac Potassium CAS 15307-...
CasNo: 15307-81-0
Molecular Formula: C14H10Cl2KNO2
Appearance: White Powder
Application: For Pharmaceutical Raw Materials
DeliveryTime: 2-4 days after confirmed your payments
PackAge: 100g/ bag, 2 kg/ bag, 25kg/ carton or ...
Port: ShangHai
ProductionCapacity: 1000 Metric Ton/Month
Purity: 99%min
Storage: Dry and cool place
Transportation: By DHL, TNT, FedEx, HKEMS, UPS, Etc
LimitNum: 10 Gram

Superiority

advantages:

hubei xinrunde chemical co., ltd is a renowned pharmaceutical manufacturer. we can offer high quality products at competitive price in quick delivery with 100% custom pass guaranteed. never stop striving to offer our best service is our philosophy. we have flexible and untraceable payment terms. as a leading manufacture, our products have been exported to germany, norway, poland, finland, spain, uk, france, russia, usa, brazil, mexico, australia, japan, korea, thailand, indonesia, uruguay and many other countries.

1. quality.every batch of steroid powders have tobetested by our qc(quality control) before they are allowed to sell.

2 . delivery we have stock, so we can delivery quickly at the very day when receive the payment. within 24 hours after receiving the payment lead time 4 or 7 days.

3 . discreet package safelyand professionally disguised package guaranteed. for your safety and to insure delivery all products will be packed in a discreet way to prevent any suspicions, no steroids related name will appear on the parcels. high successful delivery rate

4 . warm after-sale service any of your question would be solved for the first as soon as possible.

Details

diclofenac potassium basic information

description references

product name:	diclofenac potassium
synonyms:	potassium diclofenac;prosorb;diclofenic potassium;benzeneaceticacid, 2-[(2,6-dichlorophenyl)amino]-, potassium salt (1:1);potassium 2-(2-(2,6-dichlorophenylamino)phenyl)acetate;diclofenac potassium;diclofenac potassium salt;2[(2,6-dichlorophenyl)amino]benzeneacetic acid potassium salt
cas:	15307-81-0
mf:	c14h10cl2kno2
mw:	334.24
einecs:	1312995-182-4
product categories:	inhibitors;active pharmaceutical ingredients;chiral;api's
mol file:	15307-81-0.mol

diclofenac potassium chemical properties

cas database reference

15307-81-0(cas database reference)

safety information

hazard codes	xn,n
risk statements	22-51/53
safety statements	61
ridadr	un 2811 6.1 / pgiii

diclofenac potassium usage and synthesis

description	dichlofenac potassium is the potassium salt of dichlofenac. it is a nonsteroidal anti-inflammatory agent that can be used to reduce inflammation and as an analgesic to reduce pain in certain conditions. it can also used to treat dysmenorrhea. it can treat inflammatory disorders such as musculoskeletal complaints, dental pain, arthritis, actinic keratosis, joint pain, acute pain and chronic pain caused by certain kinds of cancers. traditional opinion proposes that diclofenac exerts its action via inhibition of prostaglandin synthesis by inhibiting cyclooxygenase-1 (cox-1) and cyclooxygenase-2 (cox-2) with relative equipotency. however, recent studies have shown that the pharmacologic activity of diclofenac goes beyond cox inhibition, and includes multimodal and, in some instances, novel mechanisms of action (moa). for example, research suggests diclofenac can inhibit the thromboxane-prostanoid receptor, affect arachidonic acid release and uptake, inhibit lipoxygenase enzymes, and activate the nitric oxide–cgmp antinociceptive pathway. other novel moas may include the inhibition of substrate p, inhibition of peroxisome proliferator activated receptor gamma (pparγ), blockage of acid-sensing ion channels, alteration of interleukin-6 production, and inhibition of n-methyl-d-aspartate (nmda) receptor hyperalgesia.
references	brogden, r. n., et al. "diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin." drugs 20.1 (1980): 24-48. gan, tong j. "diclofenac: an update on its mechanism of action and safety profile." current medical research and opinion 26.7 (2010): 1715-1731. riihiluoma, p., e. wuolijoki, and m. o. pulkkinen. "treatment of primary dysmenorrhea with diclofenac sodium." european journal of obstetrics & gynecology and reproductive biology 12.3 (1981): 189-194.
definition	chebi: the potassium salt of diclofenac.